Home / Inspections / 1112627

1112627

Boehringer Ingelheim Pharmaceuticals, Inc. — FEI 1219205

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
December 12, 2019
Fiscal Year
2020
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Ridgefield, CT (United States)

Additional Details

Sponsor, Contract Research Organization

Facility

Other inspections at this facility

  • 1281125 (VAI Thu Sep 11 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1219707 (NAI Fri Sep 22 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1073537 (VAI Thu Dec 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1004536 (VAI Tue Feb 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 963057 (NAI Fri Feb 26 2016 00:00:00 GMT+0000 (Coordinated Universal Time))

Citations

IDCFRDescription
748021 CFR 312.50Ensuring compliance with plan and protocol
755721 CFR 312.56(b)Notification of FDA of termination of investigator
755821 CFR 312.57(c)Record retention requirement